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Single-use and sustainability:                     
Continued studies using LCA tools  
William Whitford
Strategic Solutions Leader
GE Healthcare, Sep. 26, 2018
ECI Single-Use Summit, Utah 
• Single-use technologies can enable today’s objectives
• Relationship of single-use technology and sustainability
• Life cycle assessment (LCA): identifying/quantifying impact
• Selected strategic insights to guide your single-use journey
Agenda
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Benefits of single-use (SU) technology
• Build time
• CapEx
• OpEx
• Flexibility
• Annual output
• Sustainability
3
• Expansion of single-use into new geographies
• Modular facilities highlighting optimized floor plans
• Incorporate broader range of single-use technologies
• Customer interest in sustainable methods / materials
Think outside the box: Pfizer chose a mobile biotech 
factory to make next-generation drugs in China
Bioprocess evolution requires new insights
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http://www.gereports.com/pfizer-will-use-ges-modular-factory-to-make-next-generation-
drugs-in-china/
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We all are concerned about the environment
New Zealand banned shopping bags
Mumbai banned all public single-use plastics
Newsweek published their Green Ranking 2017
• Sealed Air Corporation ranked #5 in the nation
• Eg, cryovac packaging; bubble wrap cushioning
With what priorities, and at what price, are the questions
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• Sustainability is one of six major trends in biopharma1, 2
• Global trends driving imperative for sustainability3
– Population/demographic shifts, employee awareness and values, more 
stringent regulatory environment, climate change, investor expectations
• Three focus areas within pharma industry control3
– Environmental impacts of manufacturing
– Sustainability integration and collaboration
– Pharmaceuticals emitted in the environment
• BPSA Sustainability Team:4
– Commitment to solutions for SUS environmental concerns 
– Among many other industry consortiums
Biopharma sustainability goals
6
1. Scott, C. Sustainability in Bioprocessing: Not Just an Afterthought, BioProcess Int. 9(10) 2011: 25-36.
2. Budzinski et al., Toward Sustainable Engineering Practices in Biologics Manufacturing, BioProcess Int. 13(11)i, December 2015.
3. Biogen 2030 Outlook On Sustainability, June 2016, https://www.biogen.com/content/dam/corporate/en_us/pdfs/corporate-citizenship-
report/2015/Biogen_2030OutlookOnSustainability_June2016.pdf
4. BPSA, http://bpsalliance.org/event/bpsa-sustainability-team-call/
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• Industry shifting towards single-use (SU) technology
• What are environmental trade-offs associated with the shift?
• How does SU technology figure in achieving sustainability goals?
Relationship of single-use (SU) technology and sustainability
Stainless steel facilities
Image courtesy of division of Industrial Biotechnology, KTH/Biotechnology GE Healthcare FlexFactory™ bioproduction operations in Marlborough, MA, USA
Ecosystem 
quality Single-use facilities
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Sustainability is a highly complex and competitive endeavor
Eg, which is most significant?
• Landfill operation
• Atmospheric carbon
Which is best end for complex / tainted plastics?
• Re-use in national recycling center?
o High process / transport carbon burden
o Delays carbon release
• Use instead of oil / gas for power generation?
o Low process / transport carbon burden
o Releases all carbon now
Environmental stress occurs in distinct arenas
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LCA:  a detailed, rigorous approach 
to environment sustainability
What is included in an LCA 
Life Cycle Assessment?
LCA:  Impact throughout product / service life cycle
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Life Cycle Assessment 
Areas of protection (damage categories)
Understanding impact of products / services across value chain
• Support decisions
• Evaluate alternatives
• Prioritize opportunities
• Mitigate environmental issues
Natural 
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end 
of life
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WAVE Bioreactor™ system + ReadyToProcess™ full process 
train for mAb production
Purpose / driver of LCA
• Compare potential impacts of multi-use vs. single-use
Results / lessons learned
• SU technology exhibits lower impact across full life cycle 
– Reduction of water for injection, process water, steam 
– Much less energy consumption / water fouling CIP, SIP
• Various SU end-of-life impacts negligible compared to use 
phase and supply chain activities
• Study was subjected to a third-party critical panel review per 
ISO 14040-44
2010 to 2012 GE SU technology LCA results
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Full process train, 2000 L scale
—Traditional
— Single-use
Result was unexpected, counterintuitive and only 
accessible through detailed LCA
Pietrzykowksi M. et al, An Environmental Life Cycle Assessment Comparison of Single-Use and Conventional 
Process Technology for the Production of Monoclonal Antibodies, J. Clean. Prod. 41, 150-162 (2013).
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LCA study has been updated and expanded
2010–2012 LCA study
mAb process
Stainless steel and SU retrofit
WAVE Bioreactor™ system and 
ReadyToProcess™ portfolio
2016-2017 LCA study
mAb and vaccine processes
Stainless steel, SU retrofit, hybrid 
Xcellerex™ bioreactors, WAVE 
Bioreactor system, HyClone™
portfolio, ÄKTA™ ready system, 
ReadyToProcess portfolio
Geography considerations
End-of-life disposal options
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New GE LCA study scope
Traditional stainless steel facilities
Image courtesy of division of Industrial Biotechnology, KTH/Biotechnology GE Healthcare FlexFactory™ biomanufacturing operations, Marlborough, MA, USA
Single-use facilities (retrofit)
Stainless steel /
single-use hybrid
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LCA study explores applications in 
stainless steel, single-use, or hybrid 
with proteins and vaccines 
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2016 - 17 (new) SU LCA study
GE Healthcare newest white paper presents data on 
• Entire value chain and multiple impact categories
• Results from hybrid facilities and vaccine product
• Three, understandable, damage category metrics
Highlights
• SU usually results in lower environmental impacts 
• End-of-life disposal minimal comparative impacts 
• Key factors: energy source and geographic setting
• The LCA model is a very useful tool in evaluations
Following the successful 2010–2012 LCA study
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2010–2012 LCA study
mAb bioprocessing configuration used in both studies
Biob. = bioburden, CIP/SIP = cleaning/sanitization in place, IEX = ion exchange chromatography, Prep. = preparation, UF/DF = ultrafiltration/diafiltration
Note: General unit operations shown; configuration can change due to scale, product choice, technologies used, etc.
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Environmental impact assessment
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Jolliet O. et al, IMPACT 2002+: a new life cycle impact assessment 
methodology, Int. J. Life Cycle Assess 8(6), 324-330 (2003) as adapted 
by Quantis in version Q2.22 of IMPACT 2002+: User Guide
Damage categories
Human health
Ecosystem quality
Climate change 
(Life support system)
Resources
Environmental Impacts
Human toxicity
Respiratory effects
Ionizing radiation
Ozone layer depletion
Photochemical oxidation
Aquatic ecotoxicity
Terrestrial ecotoxicity
Aquatic acidification
Aquatic eutrophication
Terrestrial acid/nutr
Land occupation
Water turbined
Global warming
Non-renewable energy
Mineral extraction
Water withdrawal
Water consumption
LCI = life cycle inventory
LCI results
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mAb LCA results
Impact comparison:  Traditional vs SU process technologies
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Impacts by process step
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mAb SU / traditional climate change impact by siting geography, ranked 
by logistics distance and electricity grid
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mAb SU / traditional freshwater consumption impact by siting geography, 
logistics distance and electricity grid
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Traditional
Single-Use
ECI Single-Use Summit, Utah 
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Comparative impact:  mAb alternative end-of-life disposal options
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Strategic insights
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mAb results are sensitive to geography
• Traditional process highly sensitive to “clean vs. dirty” electrical grid 
• SU process sensitive to both electrical grid and transport logistics
mAb results are sensitive to process scale
• Impacts (per unit mAb) decrease with increasing production volume 
No mAb sensitivity to end-of-life disposal
• Disposal of SU materials is not a significant factor
September 26, 2018ECI Single-Use Summit, Utah 
Single-use technologies 
reduces environmental 
impact… usually
1
Region of choice for 
facility does contribute 
significantly to 
environmental impact 
due to transport and 
grid differences
2 Single-use disposal at 
end-of-life does not
contribute significantly 
to environmental impact
3
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Hybrid process results example
Example 2016 - 17 SU LCA conclusion
Contribution from 3 activity stages
• Supply chain
• Use (mfg.)
• End-of-life 
For 3 configurations 
• Traditional
• Single-use
• Hybrid 
For 2,000 L scale bioprocessing in Boston
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2010–2012 LCA study
Suggested guidance
29
SU often less impactful than traditional for mAb processes, with 
some exceptions: combination of geography and process scale
Early results from vaccine (AdV) modeling suggest similar 
sustainability benefits of single-use process technology
Use caution when extending these findings: The complex 
relationships between key influencing variables may require 
exploration of results specific to a given scenario
September 26, 2018ECI Single-Use Summit, Utah 
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GE Healthcare – Bioprocess sustainability
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• Fortem one single-use platform 
film for bioprocess
• Simplify qualification and 
supply management
• Secure supply chain, committed 
to sustainable practices
• Working for a “greener” delivery
• Europe pilot program reduced CO2 
impacts w/ better On Time Delivery
• Next: evaluating global mode shifts, 
including lower-footprint multi-
mode options for customers
• Removing instructions from on all 
chromatography resin packs >5L
• Pre-printed labels with website link
• Eliminate ~1,000 kg weight per year 
– usage and transport
Continuing the dialogue This is an ongoing, collaborative study 
addressing industry sustainability questions
Let’s work together as an industry to share 
and apply these and other learnings around 
sustainability
 BPSA Sustainability Committee
 Conferences, workshops like this
 Reviewed publications, book chapters
Look for more communications from us in 
2019 about bioprocess and single-use 
sustainability
Phase II LCA results now 
available in new white paper
Contact us!
http://bioprocess.gelifesciences.com/ge-resources/single-use-solutions/
BioPharm Services
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Biomanufacturing is a highly complex and competitive industry
• Shorter time-to market
• Increased plant utilization
• Increased footprint productivity
• Intensified temporal productivity
• Less variability, failures, and waste
• Multi-product, flexible manufacturing
• Higher manufacturing quality standards
Desired outcomes
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Digital 
techniques
Increased 
competition
(biosimilars)
Localized 
manufacturing
Novel 
manufacturing 
modes
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Flexible 
manufacturing 
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